European Pharmaceutical Review

DECEMBER 15, 2022

Lilly’s 30×30 initiative aims to improve access to quality healthcare for 30 million people living in limited-resource settings, annually, by 2030. Lilly will also provide a pro-bono technology transfer to enable EVA Pharma to formulate, fill and finish insulin vials and cartridges. . WHO’s Global Diabetes Compact.

Packaging 84

Packaging Communication 84

ISPE

NOVEMBER 22, 2022

I presented on planning and executing and designing fill lines, RABS, Isolators, and transfers – along with the differences between processing potent compounds versus non- potent compounds. ISPE Aseptic is one of those conferences where the depth of knowledge astounds me. 4) You Will Find Different Growth Points throughout Your Career.

Compounding 98

Compounding Packaging Dosage Vaccines 98

ISPE

SEPTEMBER 11, 2023

4 , 5 Additionally, reducing shipping limitations—such as packaging, storage, and transportation durations—helps speed up patient access in certain instances while ensuring there is no negative impact to the product’s critical quality attributes (CQAs). These new operating models can help enable and accelerate the efforts of Pharma 4.0™

Health and Personal Care Stores 52

Health and Personal Care Stores Vaccines Packaging Documentation 52

ISPE

MARCH 15, 2023

1 This view prioritizes steps that reduce the use of natural resources and the release of undesirable products such as carbon to the atmosphere or plastics to landfills. Table 1: Facility environmental sustainability tools and example values. 7 An integrative (vs. 7 An integrative (vs. 7 An integrative (vs.

Packaging 52

Packaging Labelling Health Compliance Process Improvement 52

ISPE

AUGUST 30, 2022

In this article, the term “raw material” refers to a material used in the manufacturing and packaging of a drug substance (DS) or a drug product (DP). Finally, the DP is packaged in a suitable container to ensure continued quality. The DP formulation and filling processes use excipients, filters, vials, and syringes.

Documentation 52

Documentation FDA Packaging Communication 52

pharmaphorum

DECEMBER 13, 2021

The Covid-19 pandemic showed what could be done with resources and collaboration to accelerate the development of vaccines. It, too, announced plans to invest $500 million in a new facility in Africa for the production, fill/finish and packaging of mRNA vaccines.

Vaccines 105

Vaccines Packaging 105

Pharmaceutical Technology

DECEMBER 8, 2022

When we think of smart manufacturing in the biopharmaceutical industry, an automated manufacturing line for filling and finishing pharmaceutical vials might come to mind. Forward-thinking suppliers, including packaging component providers, are also looking at how they can improve their processes through digital technologies.

Packaging 98

Packaging Vaccines Communication 98